Phase 1 Abnormality Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
Noise-induced hearing lossHearing LossHearing Disorders+22 more
University of Colorado, Denver344 enrolled1 locationNCT07304024
Recruiting
Phase 1
FAPI-74 PET/CT in Adults With Fibrosis
Fibrosis (Morphologic Abnormality)
Abramson Cancer Center at Penn Medicine45 enrolled1 locationNCT06413355
Recruiting
Phase 1Phase 2
Spermatogonial Differentiation Via Testicular Organoid
Gene AbnormalityInfertility, MaleSterility, Male
CellARTs Inc.100 enrolled1 locationNCT06841861
Recruiting
Phase 1
A study on the satiety effect of Caralluma fimbriata extract for people with Prader - Willi syndrome (PWS).”
Prader-Willi syndrome (PWS) PWS is caused by three types of abnormality in chromosome 15 at a prevalence rate of 1:11,000 to 1:22,000. The defining feature of PWS is food-seeking behaviour due to constant hunger. Hyperphagia and obesity are one of the main burdens in PWS and obesity is linked to increased morbidity and mortality.
Victoria University16 enrolled1 locationACTRN12611000334909